United States Biotechnology & Medical Research

G1 Therapeutics Inc (GTHX)

Track

Track

G1 Therapeutics Inc. experienced multiple insider trading transactions throughout the second quarter of 2024. Key executives, including the CEO and CFO, executed various share sales between April and July. No recent activity has occurred within the last three months, rendering current market performance analysis outside the scope of this historical data review.
Ticker: GTHX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for G1 Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.3
Perry Andrew Chief Commercial Officer Officer
Transaction date
Sale
Price
246.54
Quantity 77,747 -26.6%
Value US$4,574,318
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
473.80
Quantity 82,960 -0.3%
Value US$3,502,766
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Sale
Price
106.77
Quantity 4,432 -3.1%
Value US$3,396,937
2.2
Bailey John E. (Jack) Jr. President and CEO Executive Director
Transaction date
Sale
Price
2.51
Quantity 7,662 -1.4%
Value US$19,214
2.2
Umstead John W. V Chief Financial Officer Officer
Transaction date
Sale
Price
2.51
Quantity 527 -0.3%
Value US$1,322
2.4
Avagliano Mark Chief Business Officer Officer
Transaction date
Sale
Price
2.51
Quantity 2,638 -1.1%
Value US$6,615
Thomas Monica R. Chief Legal & People Officer Officer
Transaction date
Sale
Price
4.27
Quantity 5,826 -5.0%
Value US$24,864
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Sale
Price
4.79
Quantity 8,151 -7.9%
Value US$39,034
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
4.79
Quantity 8,151 -4.8%
Value US$39,034
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
4.79
Quantity 8,151 -4.8%
Value US$39,034
2.4
Avagliano Mark Chief Business Officer Officer
Transaction date
Sale
Price
4.79
Quantity 8,151 -3.7%
Value US$39,034
2.2
Umstead John W. V Chief Financial Officer Officer
Transaction date
Sale
Price
4.79
Quantity 8,151 -5.1%
Value US$39,034
2.3
Perry Andrew Chief Commercial Officer Officer
Transaction date
Sale
Price
4.79
Quantity 8,151 -9.4%
Value US$39,034
2.2
Bailey John E. (Jack) Jr. President and CEO Executive Director
Transaction date
Sale
Price
4.79
Quantity 37,258 -7.6%
Value US$178,421
MARK VELLECA Director Non-Executive Director
Transaction date
Proposed sale
Price
4.80
Quantity 28,393
Value US$136,389
2.2
Umstead John W. V Chief Financial Officer Officer
Transaction date
Sale
Price
3.02
Quantity 6,547 -5.0%
Value US$19,752
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.62
Quantity 28,600 -14.4%
Value US$132,143
2.9
RAJESH MALIK Officer Officer
Transaction date
Proposed sale
Price
4.62
Quantity 28,600
Value US$132,143
MARK VELLECA Director Non-Executive Director
Transaction date
Proposed sale
Price
3.20
Quantity 60,000
Value US$192,288
2.4
Avagliano Mark Chief Business Officer Officer
Transaction date
Sale
Price
2.94
Quantity 721 -0.6%
Value US$2,121
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Sale
Price
2.94
Quantity 721 -0.7%
Value US$2,121
2.2
Umstead John W. V Chief Financial Officer Officer
Transaction date
Sale
Price
2.94
Quantity 111 -0.1%
Value US$327
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
2.94
Quantity 721 -0.4%
Value US$2,121
2.4
Avagliano Mark Chief Business Officer Officer
Transaction date
Sale
Price
3.12
Quantity 2,602 -2.1%
Value US$8,115
2.4
Avagliano Mark Chief Business Officer Officer
Transaction date
Sale
Price
3.12
Quantity 758 -0.6%
Value US$2,364
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Sale
Price
3.12
Quantity 2,261 -2.1%
Value US$7,052
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Sale
Price
3.12
Quantity 758 -0.7%
Value US$2,364
2.2
Bailey John E. (Jack) Jr. President and CEO Executive Director
Transaction date
Sale
Price
3.12
Quantity 9,094 -1.8%
Value US$28,363
2.2
Bailey John E. (Jack) Jr. President and CEO Executive Director
Transaction date
Sale
Price
3.12
Quantity 2,592 -0.5%
Value US$8,084
2.2
Umstead John W. V Chief Financial Officer Officer
Transaction date
Sale
Price
3.12
Quantity 379 -0.3%
Value US$1,182
2.2
Umstead John W. V Chief Financial Officer Officer
Transaction date
Sale
Price
3.12
Quantity 253 -0.2%
Value US$789
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
3.12
Quantity 2,261 -1.3%
Value US$7,052
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
3.12
Quantity 758 -0.4%
Value US$2,364
2.3
Perry Andrew Chief Commercial Officer Officer
Transaction date
Sale
Price
3.12
Quantity 2,034 -2.3%
Value US$6,344
2.3
Perry Andrew Chief Commercial Officer Officer
Transaction date
Sale
Price
3.12
Quantity 379 -0.4%
Value US$1,182
2.2
Bailey John E. (Jack) Jr. President and CEO Executive Director
Transaction date
Sale
Price
3.27
Quantity 32,983 -7.6%
Value US$108,006
MARK VELLECA Director Non-Executive Director
Transaction date
Proposed sale
Price
3.40
Quantity 60,000
Value US$203,916
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.02
Quantity 12,400 -8.3%
Value US$49,863
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Planned sale
Price
3.06
Quantity 21,439 -13.6%
Value US$65,659
2.9
RAJESH MALIK Officer Officer
Transaction date
Proposed sale
Price
3.41
Quantity 33,839
Value US$115,522
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
2.02
Quantity 2,714 -2.3%
Value US$5,482
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
2.00
Quantity 57,286 -33.1%
Value US$114,492
MARK VELLECA Director Non-Executive Director
Transaction date
Proposed sale
Price
2.00
Quantity 60,000
Value US$119,974
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Planned sale
Price
2.45
Quantity 1,361 -1.0%
Value US$3,339
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Planned sale
Price
2.45
Quantity 1,361 -1.9%
Value US$3,339
2.2
Bailey John E. (Jack) Jr. President and CEO Executive Director
Transaction date
Planned sale
Price
2.45
Quantity 2,719 -0.6%
Value US$6,672
2.3
Perry Andrew Chief Commercial Officer Officer
Transaction date
Planned sale
Price
2.45
Quantity 355 -0.6%
Value US$871
3.2
Moses Jennifer K. CFO Officer
Transaction date
Sale
Price
5.41
Quantity 729 -1.2%
Value US$3,942
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Sale
Price
5.41
Quantity 729 -2.0%
Value US$3,942
2.1
Hanson James S. General Counsel Officer
Transaction date
Sale
Price
5.41
Quantity 729 -1.7%
Value US$3,942
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
5.41
Quantity 729 -0.7%
Value US$3,942
2.2
Bailey John E. (Jack) Jr. President and CEO Executive Director
Transaction date
Sale
Price
5.58
Quantity 5,607 -2.0%
Value US$31,262
2.3
Perry Andrew Chief Commercial Officer Officer
Transaction date
Sale
Price
5.58
Quantity 820 -3.7%
Value US$4,572
3.2
Moses Jennifer K. CFO Officer
Transaction date
Sale
Price
5.58
Quantity 1,639 -2.7%
Value US$9,138
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Sale
Price
5.58
Quantity 1,639 -4.2%
Value US$9,138
2.1
Hanson James S. General Counsel Officer
Transaction date
Sale
Price
5.58
Quantity 1,639 -3.8%
Value US$9,138
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
5.58
Quantity 1,639 -1.6%
Value US$9,138
2.2
Bailey John E. (Jack) Jr. President and CEO Executive Director
Transaction date
Sale
Price
5.85
Quantity 32,019 -10.2%
Value US$187,452
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
11.70
Quantity 15,000 -11.5%
Value US$175,490
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
13.50
Quantity 20,000 -14.7%
Value US$270,044
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.71
Quantity 18,000 -19.7%
Value US$282,746
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
12.64
Quantity 80,000 -40.8%
Value US$1,010,904
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
5.17
Quantity 648 -0.9%
Value US$3,351
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Sale
Price
5.17
Quantity 648 -3.0%
Value US$3,351
2.5
MURDOCK TERRY L Chief Operating Officer Officer
Transaction date
Sale
Price
10.61
Quantity 1,445 -6.3%
Value US$15,334
2.1
Hanson James S. General Counsel Officer
Transaction date
Sale
Price
10.61
Quantity 1,445 -5.4%
Value US$15,334
2.4
Avagliano Mark Chief Business Officer Officer
Transaction date
Sale
Price
10.61
Quantity 1,445 -6.3%
Value US$15,334
2.9
Malik Rajesh Chief Medical Officer Officer
Transaction date
Sale
Price
10.61
Quantity 1,445 -2.2%
Value US$15,334
3.2
Moses Jennifer K. CFO Officer
Transaction date
Sale
Price
10.61
Quantity 1,445 -3.9%
Value US$15,334
2.2
Bailey John E. (Jack) Jr. President and CEO Executive Director
Transaction date
Sale
Price
10.41
Quantity 34,125 -12.8%
Value US$355,262
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
21.77
Quantity 10,000 -14.1%
Value US$217,728
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
21.74
Quantity 10,000 -14.1%
Value US$217,384
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
22.39
Quantity 10,000 -14.1%
Value US$223,909
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
20.54
Quantity 10,000 -19.6%
Value US$205,413
Velleca Mark A. Non-Executive Director
Transaction date
Planned sale
Price
20.07
Quantity 10,000 -19.6%
Value US$200,691
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-08 2024-07-05 S Sale
2.3
Perry Andrew

Chief Commercial Officer

Officer
77,747 -26.6%
246.54
US$4,574,318 		77,747 -26.6% 246.54 US$4,574,318
2024-07-08 2024-07-05 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
82,960 -0.3%
473.80
US$3,502,766 		82,960 -0.3% 473.80 US$3,502,766
2024-07-08 2024-07-05 S Sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
4,432 -3.1%
106.77
US$3,396,937 		4,432 -3.1% 106.77 US$3,396,937
2024-07-08 2024-07-05 S Sale
2.2
Bailey John E. (Jack) Jr.

President and CEO

Executive Director
7,662 -1.4%
2.51
US$19,214 		7,662 -1.4% 2.51 US$19,214
2024-07-08 2024-07-05 S Sale
2.2
Umstead John W. V

Chief Financial Officer

Officer
527 -0.3%
2.51
US$1,322 		527 -0.3% 2.51 US$1,322
2024-07-08 2024-07-05 S Sale
2.4
Avagliano Mark

Chief Business Officer

Officer
2,638 -1.1%
2.51
US$6,615 		2,638 -1.1% 2.51 US$6,615
2024-05-24 2024-05-23 S Sale
Thomas Monica R.

Chief Legal & People Officer

Officer
5,826 -5.0%
4.27
US$24,864 		5,826 -5.0% 4.27 US$24,864
2024-05-15 2024-05-13 S Sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
8,151 -7.9%
4.79
US$39,034 		8,151 -7.9% 4.79 US$39,034
2024-05-15 2024-05-13 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
8,151 -4.8%
4.79
US$39,034 		8,151 -4.8% 4.79 US$39,034
2024-05-15 2024-05-13 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
8,151 -4.8%
4.79
US$39,034 		8,151 -4.8% 4.79 US$39,034
2024-05-15 2024-05-13 S Sale
2.4
Avagliano Mark

Chief Business Officer

Officer
8,151 -3.7%
4.79
US$39,034 		8,151 -3.7% 4.79 US$39,034
2024-05-15 2024-05-13 S Sale
2.2
Umstead John W. V

Chief Financial Officer

Officer
8,151 -5.1%
4.79
US$39,034 		8,151 -5.1% 4.79 US$39,034
2024-05-15 2024-05-13 S Sale
2.3
Perry Andrew

Chief Commercial Officer

Officer
8,151 -9.4%
4.79
US$39,034 		8,151 -9.4% 4.79 US$39,034
2024-05-15 2024-05-13 S Sale
2.2
Bailey John E. (Jack) Jr.

President and CEO

Executive Director
37,258 -7.6%
4.79
US$178,421 		37,258 -7.6% 4.79 US$178,421
2024-04-09 2024-04-09 PrS Proposed sale
MARK VELLECA

Director

Non-Executive Director
28,393
4.80
US$136,389 		28,393 4.80 US$136,389
2024-03-20 2024-03-18 S Sale
2.2
Umstead John W. V

Chief Financial Officer

Officer
6,547 -5.0%
3.02
US$19,752 		6,547 -5.0% 3.02 US$19,752
2024-02-13 2024-02-12 PlS Planned sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
28,600 -14.4%
4.62
US$132,143 		28,600 -14.4% 4.62 US$132,143
2024-02-12 2024-02-12 PrS Proposed sale
2.9
RAJESH MALIK

Officer

Officer
28,600
4.62
US$132,143 		28,600 4.62 US$132,143
2024-01-09 2024-01-09 PrS Proposed sale
MARK VELLECA

Director

Non-Executive Director
60,000
3.20
US$192,288 		60,000 3.20 US$192,288
2024-01-08 2024-01-04 S Sale
2.4
Avagliano Mark

Chief Business Officer

Officer
721 -0.6%
2.94
US$2,121 		721 -0.6% 2.94 US$2,121
2024-01-08 2024-01-04 S Sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
721 -0.7%
2.94
US$2,121 		721 -0.7% 2.94 US$2,121
2024-01-08 2024-01-04 S Sale
2.2
Umstead John W. V

Chief Financial Officer

Officer
111 -0.1%
2.94
US$327 		111 -0.1% 2.94 US$327
2024-01-08 2024-01-04 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
721 -0.4%
2.94
US$2,121 		721 -0.4% 2.94 US$2,121
2024-01-08 2024-01-03 S Sale
2.4
Avagliano Mark

Chief Business Officer

Officer
2,602 -2.1%
3.12
US$8,115 		2,602 -2.1% 3.12 US$8,115
2024-01-08 2024-01-03 S Sale
2.4
Avagliano Mark

Chief Business Officer

Officer
758 -0.6%
3.12
US$2,364 		758 -0.6% 3.12 US$2,364
2024-01-08 2024-01-03 S Sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
2,261 -2.1%
3.12
US$7,052 		2,261 -2.1% 3.12 US$7,052
2024-01-08 2024-01-03 S Sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
758 -0.7%
3.12
US$2,364 		758 -0.7% 3.12 US$2,364
2024-01-08 2024-01-03 S Sale
2.2
Bailey John E. (Jack) Jr.

President and CEO

Executive Director
9,094 -1.8%
3.12
US$28,363 		9,094 -1.8% 3.12 US$28,363
2024-01-08 2024-01-03 S Sale
2.2
Bailey John E. (Jack) Jr.

President and CEO

Executive Director
2,592 -0.5%
3.12
US$8,084 		2,592 -0.5% 3.12 US$8,084
2024-01-08 2024-01-03 S Sale
2.2
Umstead John W. V

Chief Financial Officer

Officer
379 -0.3%
3.12
US$1,182 		379 -0.3% 3.12 US$1,182
2024-01-08 2024-01-03 S Sale
2.2
Umstead John W. V

Chief Financial Officer

Officer
253 -0.2%
3.12
US$789 		253 -0.2% 3.12 US$789
2024-01-08 2024-01-03 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
2,261 -1.3%
3.12
US$7,052 		2,261 -1.3% 3.12 US$7,052
2024-01-08 2024-01-03 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
758 -0.4%
3.12
US$2,364 		758 -0.4% 3.12 US$2,364
2024-01-08 2024-01-03 S Sale
2.3
Perry Andrew

Chief Commercial Officer

Officer
2,034 -2.3%
3.12
US$6,344 		2,034 -2.3% 3.12 US$6,344
2024-01-08 2024-01-03 S Sale
2.3
Perry Andrew

Chief Commercial Officer

Officer
379 -0.4%
3.12
US$1,182 		379 -0.4% 3.12 US$1,182
2024-01-02 2024-01-02 S Sale
2.2
Bailey John E. (Jack) Jr.

President and CEO

Executive Director
32,983 -7.6%
3.27
US$108,006 		32,983 -7.6% 3.27 US$108,006
2023-12-12 2023-12-12 PrS Proposed sale
MARK VELLECA

Director

Non-Executive Director
60,000
3.40
US$203,916 		60,000 3.40 US$203,916
2023-12-13 2023-12-11 PlS Planned sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
12,400 -8.3%
4.02
US$49,863 		12,400 -8.3% 4.02 US$49,863
2023-12-13 2023-12-11 PlS Planned sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
21,439 -13.6%
3.06
US$65,659 		21,439 -13.6% 3.06 US$65,659
2023-12-11 2023-12-11 PrS Proposed sale
2.9
RAJESH MALIK

Officer

Officer
33,839
3.41
US$115,522 		33,839 3.41 US$115,522
2023-08-10 2023-08-08 PlS Planned sale
Velleca Mark A.
Non-Executive Director
2,714 -2.3%
2.02
US$5,482 		2,714 -2.3% 2.02 US$5,482
2023-08-10 2023-08-08 PlS Planned sale
Velleca Mark A.
Non-Executive Director
57,286 -33.1%
2.00
US$114,492 		57,286 -33.1% 2.00 US$114,492
2023-08-08 2023-08-08 PrS Proposed sale
MARK VELLECA

Director

Non-Executive Director
60,000
2.00
US$119,974 		60,000 2.00 US$119,974
2023-07-07 2023-07-05 PlS Planned sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
1,361 -1.0%
2.45
US$3,339 		1,361 -1.0% 2.45 US$3,339
2023-07-07 2023-07-05 PlS Planned sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
1,361 -1.9%
2.45
US$3,339 		1,361 -1.9% 2.45 US$3,339
2023-07-07 2023-07-05 PlS Planned sale
2.2
Bailey John E. (Jack) Jr.

President and CEO

Executive Director
2,719 -0.6%
2.45
US$6,672 		2,719 -0.6% 2.45 US$6,672
2023-07-07 2023-07-05 PlS Planned sale
2.3
Perry Andrew

Chief Commercial Officer

Officer
355 -0.6%
2.45
US$871 		355 -0.6% 2.45 US$871
2023-01-05 2023-01-05 S Sale
3.2
Moses Jennifer K.

CFO

Officer
729 -1.2%
5.41
US$3,942 		729 -1.2% 5.41 US$3,942
2023-01-05 2023-01-05 S Sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
729 -2.0%
5.41
US$3,942 		729 -2.0% 5.41 US$3,942
2023-01-05 2023-01-05 S Sale
2.1
Hanson James S.

General Counsel

Officer
729 -1.7%
5.41
US$3,942 		729 -1.7% 5.41 US$3,942
2023-01-05 2023-01-05 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
729 -0.7%
5.41
US$3,942 		729 -0.7% 5.41 US$3,942
2023-01-05 2023-01-04 S Sale
2.2
Bailey John E. (Jack) Jr.

President and CEO

Executive Director
5,607 -2.0%
5.58
US$31,262 		5,607 -2.0% 5.58 US$31,262
2023-01-05 2023-01-04 S Sale
2.3
Perry Andrew

Chief Commercial Officer

Officer
820 -3.7%
5.58
US$4,572 		820 -3.7% 5.58 US$4,572
2023-01-05 2023-01-04 S Sale
3.2
Moses Jennifer K.

CFO

Officer
1,639 -2.7%
5.58
US$9,138 		1,639 -2.7% 5.58 US$9,138
2023-01-05 2023-01-04 S Sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
1,639 -4.2%
5.58
US$9,138 		1,639 -4.2% 5.58 US$9,138
2023-01-05 2023-01-04 S Sale
2.1
Hanson James S.

General Counsel

Officer
1,639 -3.8%
5.58
US$9,138 		1,639 -3.8% 5.58 US$9,138
2023-01-05 2023-01-04 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
1,639 -1.6%
5.58
US$9,138 		1,639 -1.6% 5.58 US$9,138
2023-01-05 2023-01-03 S Sale
2.2
Bailey John E. (Jack) Jr.

President and CEO

Executive Director
32,019 -10.2%
5.85
US$187,452 		32,019 -10.2% 5.85 US$187,452
2022-10-20 2022-10-18 PlS Planned sale
Velleca Mark A.
Non-Executive Director
15,000 -11.5%
11.70
US$175,490 		15,000 -11.5% 11.70 US$175,490
2022-09-22 2022-09-20 PlS Planned sale
Velleca Mark A.
Non-Executive Director
20,000 -14.7%
13.50
US$270,044 		20,000 -14.7% 13.50 US$270,044
2022-09-16 2022-09-13 PlS Planned sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
18,000 -19.7%
15.71
US$282,746 		18,000 -19.7% 15.71 US$282,746
2022-08-18 2022-08-16 PlS Planned sale
Velleca Mark A.
Non-Executive Director
80,000 -40.8%
12.64
US$1,010,904 		80,000 -40.8% 12.64 US$1,010,904
2022-07-06 2022-07-05 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
648 -0.9%
5.17
US$3,351 		648 -0.9% 5.17 US$3,351
2022-07-06 2022-07-05 S Sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
648 -3.0%
5.17
US$3,351 		648 -3.0% 5.17 US$3,351
2022-01-05 2022-01-05 S Sale
2.5
MURDOCK TERRY L

Chief Operating Officer

Officer
1,445 -6.3%
10.61
US$15,334 		1,445 -6.3% 10.61 US$15,334
2022-01-05 2022-01-05 S Sale
2.1
Hanson James S.

General Counsel

Officer
1,445 -5.4%
10.61
US$15,334 		1,445 -5.4% 10.61 US$15,334
2022-01-05 2022-01-05 S Sale
2.4
Avagliano Mark

Chief Business Officer

Officer
1,445 -6.3%
10.61
US$15,334 		1,445 -6.3% 10.61 US$15,334
2022-01-05 2022-01-05 S Sale
2.9
Malik Rajesh

Chief Medical Officer

Officer
1,445 -2.2%
10.61
US$15,334 		1,445 -2.2% 10.61 US$15,334
2022-01-05 2022-01-05 S Sale
3.2
Moses Jennifer K.

CFO

Officer
1,445 -3.9%
10.61
US$15,334 		1,445 -3.9% 10.61 US$15,334
2022-01-05 2022-01-03 S Sale
2.2
Bailey John E. (Jack) Jr.

President and CEO

Executive Director
34,125 -12.8%
10.41
US$355,262 		34,125 -12.8% 10.41 US$355,262
2021-06-17 2021-06-17 PlS Planned sale
Velleca Mark A.
Non-Executive Director
10,000 -14.1%
21.77
US$217,728 		10,000 -14.1% 21.77 US$217,728
2021-06-17 2021-06-16 PlS Planned sale
Velleca Mark A.
Non-Executive Director
10,000 -14.1%
21.74
US$217,384 		10,000 -14.1% 21.74 US$217,384
2021-06-17 2021-06-15 PlS Planned sale
Velleca Mark A.
Non-Executive Director
10,000 -14.1%
22.39
US$223,909 		10,000 -14.1% 22.39 US$223,909
2021-05-13 2021-05-13 PlS Planned sale
Velleca Mark A.
Non-Executive Director
10,000 -19.6%
20.54
US$205,413 		10,000 -19.6% 20.54 US$205,413
2021-05-13 2021-05-12 PlS Planned sale
Velleca Mark A.
Non-Executive Director
10,000 -19.6%
20.07
US$200,691 		10,000 -19.6% 20.07 US$200,691
Explore more

More insider trading research around G1 Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America